BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Xia Q, Lin J. Identification of the potential oncogenes in glioblastoma based on bioinformatic analysis and elucidation of the underlying mechanisms. Oncol Rep 2018;40:715-25. [PMID: 29901201 DOI: 10.3892/or.2018.6483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 East P, Kelly GP, Biswas D, Marani M, Hancock DC, Creasy T, Sachsenmeier K, Swanton C, Downward J, de Carné Trécesson S; TRACERx consortium. RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma. Nat Commun 2022;13:5632. [PMID: 36163168 DOI: 10.1038/s41467-022-33290-0] [Reference Citation Analysis]
2 Rocchi A, Wollebo HS, Khalili K. Protein Quality Control in Glioblastoma: A Review of the Current Literature with New Perspectives on Therapeutic Targets. IJMS 2022;23:9734. [DOI: 10.3390/ijms23179734] [Reference Citation Analysis]
3 Karami Fath M, Karimfar N, Fazlollahpour Naghibi A, Shafa S, Ghasemi Shiran M, Ataei M, Dehghanzadeh H, Nabi Afjadi M, Ghadiri T, Payandeh Z, Tarhriz V. Revisiting characteristics of oncogenic extrachromosomal DNA as mobile enhancers on neuroblastoma and glioma cancers. Cancer Cell Int 2022;22:200. [PMID: 35614494 DOI: 10.1186/s12935-022-02617-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mokgautsi N, Kuo YC, Tang SL, Liu FC, Chen SJ, Wu ATH, Huang HS. Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures. Cancers (Basel) 2022;14:262. [PMID: 35008426 DOI: 10.3390/cancers14010262] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen M, Yan C, Zhao X. Research Progress on Circular RNA in Glioma. Front Oncol 2021;11:705059. [PMID: 34745938 DOI: 10.3389/fonc.2021.705059] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Wang X, Liu S, Shao Z, Zhang P. Bioinformatic analysis of the potential molecular mechanism of PAK7 expression in glioblastoma. Mol Med Rep 2020;22:1362-72. [PMID: 32626960 DOI: 10.3892/mmr.2020.11206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Li Q, Zhang L, Jiang J, Zhang Y, Wang X, Zhang Q, Wang Y, Liu C, Li F. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis. BMC Med Genomics. 2019;12:198. [PMID: 31870357 DOI: 10.1186/s12920-019-0645-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
8 Jia D, Lin W, Tang H, Cheng Y, Xu K, He Y, Geng W, Dai Q. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma. Aging (Albany NY) 2019;11:5579-92. [PMID: 31395792 DOI: 10.18632/aging.102139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]